Sort   by:  
 Page size 
UnknownEnhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
Not available
S-EPMC8092804 | biostudies-literature
UnknownThe MEK 1/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM-coated PLGA-PEG nanoparticles.
Not available
S-EPMC8995400 | biostudies-literature
UnknownPolydopamine functionalized VEGF gene-activated 3D printed scaffolds for bone regeneration.
Not available
S-EPMC8697638 | biostudies-literature
UnknownSynthetically lethal nanoparticles for treatment of endometrial cancer.
Not available
S-EPMC5762267 | biostudies-literature
UnknownA ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer.
Not available
S-EPMC10092294 | biostudies-literature
UnknownSolubilized ubiquinol for preserving corneal function.
Not available
S-EPMC8325625 | biostudies-literature
UnknownInjectable long-acting ivacaftor-loaded poly (lactide-co-glycolide) microparticle formulations for the treatment of cystic fibrosis: In vitro characterization and in vivo pharmacokinetics in mice.
Not available
S-EPMC10843602 | biostudies-literature
Sort   by:  
 Page size